← Leaderboards
Nicholas S Duesbery
Van Andel Research Institute
$3,289,607
Attributed
$6,135,748
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–10$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$6,135,748 · 3
By mechanism
UC2$4,269,212 · 1
R01$1,375,136 · 1
R21$491,400 · 1
Top collaborators
- Mark W Neff2 shared
- Jeffrey M. Trent2 shared
Others in their field
Top investigators on “Angiogenesis Factor”
- Walter John Curran · Thomas Jefferson University$26,641,549
- Michael Simons · Yale University$25,695,668
- Martin Friedlander · Scripps Research Institute$24,592,210
- Aleksander S. Popel · Johns Hopkins University$20,020,459
- David A Cheresh · Scripps Research Institute$19,350,106
- Tatiana V Byzova · Cleveland Clinic Foundation$16,529,926
Research focus
Angiogenesis FactorMitogen Activated Protein KinaseNeoplasm /Cancer Blood SupplyAthymic MouseNeoplasm /Cancer TransplantationInnovationCell ProliferationBiochemical PathwayCell LineHemangiosarcomaTumorSite Directed MutagenesisNeoplasm /Cancer ChemotherapySarcomaToxinBackArchivesAngiogenesisAdvisory CommitteesCarcinomaBreedingBlood VesselsCancer ModelAlgorithms
Grant awards (11)
Canine Hereditary Cancer Consortium: From Bark to Bedside$2,139,485
UC2 · FY2010 · CA
Canine Hereditary Cancer Consortium: From Bark to Bedside$2,129,727
UC2 · FY2009 · CA
MEK singaling in sarcoma growth and vascularization$318,389
R01 · FY2007 · CA · contact PI
MEK singaling in sarcoma growth and vascularization.$19,510
R01 · FY2007 · CA · contact PI
MEK singaling in sarcoma growth and vascularization.$327,898
R01 · FY2006 · CA · contact PI
MEK singaling in sarcoma growth and vascularization.$19,510
R01 · FY2006 · CA · contact PI
MEK singaling in sarcoma growth and vascularization.$335,790
R01 · FY2005 · CA
Effects of tumor lethal factor on Kaposi's Sarcoma$245,700
R21 · FY2005 · CA
MEK singaling in sarcoma growth and vascularization.$18,249
R01 · FY2005 · CA
MEK singaling in sarcoma growth and vascularization$335,790
R01 · FY2004 · CA
Effects of tumor lethal factor on Kaposi's Sarcoma$245,700
R21 · FY2004 · CA